Erlonat 150 Tablet (Erlonat 150) is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells. Erlonat 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer. Erlonat 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal.
Product details
Country of Origin |
Made in India |
Storage |
ROOM TEMPERATURE |
Therapeutic Uses |
LUNG CANCER |
Shelf life |
2 YEARS |
Form |
Tablet |
Packaging Size |
STRIPS |
Treatment |
Erlonat 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer |
Manufacturer |
NATCO |
Composition |
ERLOTINIB |
Brand |
ERLONAT |
Price:
![]() |
NIBA HEALTHCARE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |